Pfizer and BioNTech recently reported comprehensive trial results that showed a 95 per cent effectiveness in preventing Covid-19. Photo: AFP/Getty Images/TNS
Pfizer applies for US emergency approval of coronavirus vaccine
- ‘We literally could be weeks away from the authorisation’ if the data is solid, says US Health Secretary Alex Azar
- The Food and Drug Administration is tentatively planning advisory meetings for three days from December 8 to discuss vaccines
Pfizer and BioNTech recently reported comprehensive trial results that showed a 95 per cent effectiveness in preventing Covid-19. Photo: AFP/Getty Images/TNS
